Weave Communications, Inc.

https://www.getweave.com

Weave Communications, Inc. is a leading vertical SaaS company headquartered in Lehi, Utah, that provides an all-in-one customer communication and engagement platform for small and medium-sized healthcare businesses. Founded in 2008, its mission is to enable small businesses to unify, modernize, and personalize every customer interaction. The company aims to revolutionize patient interaction from the initial contact through to billing, serving as a comprehensive operational hub for healthcare practices.

Weave offers a suite of integrated tools designed to streamline practice operations and enhance the patient experience. Key products and services include a VoIP phone system, two-way texting, online scheduling, automated appointment reminders, and a robust payments platform that supports text-to-pay, card-on-file, and buy-now-pay-later options. The platform also features reviews management, digital forms, team chat, call analytics, and AI-powered functionalities such as an AI Receptionist and Call Intelligence. These solutions are purpose-built for dental, optometry, medical, and veterinary offices, integrating seamlessly with existing practice management and electronic medical record systems.

Under the leadership of CEO Brett White, Weave has demonstrated strong market performance, reporting accelerated revenue growth and increased profitability, with over 50% of its customer locations now utilizing embedded AI tools. The company recently announced strong first-quarter 2026 financial results, surpassing analyst expectations. Weave has been recognized in G2's 2026 Best Software Awards for healthcare software products and holds an exclusive endorsement from the American Dental Association as a patient engagement platform. These achievements underscore its position as a key innovator in patient engagement and payment solutions within the healthcare sector.

Latest updates

Weave Accelerates Growth, Eyes AI-Powered Patient Journey Dominance

  • Weave reported Q1 2026 revenue of $65.5 million, a 17.4% year-over-year increase.
  • The company achieved record customer location additions in Q1 2026.
  • Non-GAAP income from operations reached $2.5 million, a significant improvement from $0.0 million in Q1 2025.
  • Over 50% of customer locations are currently utilizing AI tools embedded within Weave's platform.
  • Weave launched Private Communications, enabling segregated practitioner inboxes for healthcare practices.

Weave's accelerated growth and focus on AI-powered solutions reflect the broader trend of digital transformation within the healthcare sector, where practices are increasingly seeking technology to streamline operations and enhance patient engagement. The company's emphasis on vertical SaaS, targeting small and medium-sized practices, positions it to capitalize on a large and fragmented market. However, the competitive landscape is intensifying, and Weave's ability to maintain its growth momentum will depend on its execution of its AI strategy and continued expansion within the healthcare vertical.

AI Integration
The success of Weave's AI receptionist hinges on seamless integration and user adoption, which will dictate its impact on overall platform value and customer retention.
Competition
Increased competition in the vertical SaaS space, particularly from larger players, could pressure Weave’s pricing and require continued innovation to maintain its growth trajectory.
Profitability
Whether Weave can sustain its improved profitability margins as it scales and invests in AI development will be a key indicator of its long-term financial health.

Weave Bolsters Call Intelligence Amid Rising Patient Cost Concerns

  • Weave has enhanced its Call Intelligence product, transforming it from an analytics tool into an AI-driven workflow engine.
  • The update prioritizes follow-ups, integrates with practice management systems (PMS), and expands enterprise/multi-location capabilities.
  • A recent poll indicates 66% of Americans worry about affording healthcare, a higher concern than utilities, food, housing, or gas.
  • Call Intelligence now supports verticals beyond dentistry, including optometry, veterinary, and various medical specialties.

Rising healthcare costs are creating a significant barrier to patient access and driving practices to seek efficiency gains. Weave's enhanced Call Intelligence aims to address this by automating workflows and improving patient communication, but the company faces competition from established PMS providers and other patient engagement platforms. The product's success will depend on its ability to demonstrably improve practice efficiency and patient outcomes in a cost-sensitive environment.

Adoption Rate
The success of Weave's enhancements hinges on the willingness of healthcare practices to adopt AI-driven workflows, which may be hindered by staff training needs and resistance to change.
PMS Integration
The depth and breadth of Call Intelligence's PMS integrations will be critical; limited compatibility could restrict adoption and limit the product's value proposition.
Market Penetration
Whether Weave can effectively expand its reach beyond its initial dental focus and capture significant market share in broader healthcare verticals remains to be seen.

Weave Bolsters Healthcare Reach Through Advisor Partnership

  • Weave (NYSE: WEAV) announced a partnership with Minted Technology Advisors to expand its reach within the healthcare sector.
  • Minted Technology Advisors' MintedCX initiative focuses on guiding healthcare practices through technology adoption, specifically patient communication and engagement.
  • The partnership aims to streamline operations for healthcare offices and improve patient care through Weave's AI-powered platform.
  • Jacob Sohn, Head of Channel Partnerships at Weave, and Marcus Minton, President of Minted Technology Advisors, jointly highlighted the value of the collaboration.

Weave's partnership with Minted Technology Advisors underscores the growing need for specialized advisory services to facilitate the adoption of complex healthcare technologies. The healthcare sector's ongoing digital transformation requires more than just software; it demands strategic guidance to ensure successful implementation and maximize ROI. This move signals Weave's intent to expand its market penetration beyond direct sales by leveraging a network of advisors to reach smaller and medium-sized practices.

Implementation Risk
The success of this partnership hinges on Minted Technology Advisors' ability to effectively integrate Weave's platform into existing healthcare workflows, which can be complex and resistant to change.
Channel Dependency
Weave's increasing reliance on partners like Minted Technology Advisors introduces a degree of dependency that could impact its growth trajectory if the relationship falters or Minted's performance declines.
Market Saturation
The healthcare patient communication and engagement market is becoming increasingly crowded; Weave must demonstrate a clear differentiation through its partnership and platform to maintain its competitive edge.

Weave Adds Engine Capital-Linked Directors Amid Shareholder Pressure

  • Weave Communications appointed Ryan Dubin and Edward Robson to its Board of Directors, effective immediately.
  • The appointments were made in connection with a cooperation agreement with Engine Capital and 2717 Partners.
  • A new Finance Committee will be formed, including David Silverman, Tyler Newton, Edward Robson, and Ryan Dubin.
  • Weave will initiate a search for a third independent director with executive-level software operating experience.
  • Robson is the Founder and CIO of 2717 Partners, while Dubin is a Director at Engine Capital.

The appointments of Robson and Dubin, backed by Engine Capital and 2717 Partners, signal a concerted effort to influence Weave's strategic direction and unlock shareholder value. This move is indicative of a broader trend of activist investors targeting SaaS companies, particularly those in the healthcare vertical, to pressure for operational improvements and increased profitability. The cooperation agreement and the formation of a new Finance Committee suggest a potential shift in Weave's governance structure and a greater emphasis on financial performance.

Governance Dynamics
The composition of the new Finance Committee and the search for a third director suggest a heightened focus on shareholder value, potentially leading to increased scrutiny of management decisions.
Execution Risk
The success of Weave's strategy will hinge on the ability of the new board members to effectively collaborate with management and drive operational improvements, particularly in light of Engine Capital's involvement.
Financial Performance
Continued top-line growth and margin expansion will be critical to validating the board's strategy and satisfying the demands of activist investors.

Weave Secures Exclusive ADA Endorsement, Boosting Dental Practice Engagement

  • Weave has been designated the exclusive patient engagement platform endorsed by the American Dental Association (ADA).
  • The endorsement is reserved for products meeting high standards for dental practices, involving a vetting process by the ADA Member Advantage board.
  • ADA members receiving the endorsement will benefit from discounts and enhanced training.
  • Weave’s platform includes features like an AI receptionist, insurance eligibility insights via RPA, and a customized phone system.
  • Weave serves approximately 40,000 customer locations and is a public company (NYSE: WEAV).

This endorsement represents a significant win for Weave, providing a strong validation of its platform and a potential catalyst for accelerated growth within the dental market. The ADA’s endorsement process carries considerable weight within the industry, and this exclusive designation creates a barrier to entry for competitors. The move highlights the increasing reliance on technology to streamline operations and enhance patient experience within the dental sector, a trend driven by rising operational costs and evolving patient expectations.

Adoption Rate
The speed at which ADA members adopt Weave’s platform will be a key indicator of the endorsement's value and Weave’s ability to penetrate a critical market segment.
Competitive Response
Other patient engagement platform providers will likely react to Weave’s exclusive endorsement, potentially leading to increased price competition or targeted marketing campaigns.
Integration Depth
The effectiveness of Weave’s integrations with practice management systems will determine the platform’s overall utility and drive long-term user retention.

Weave Executives to Address Investors at Raymond James Conference

  • Weave (NYSE: WEAV) will present at the Raymond James Institutional Investors Conference on March 2, 2026, in Orlando, Florida.
  • CEO Brett White and CFO Jason Christiansen will host a fireside chat and participate in one-on-one meetings.
  • The presentation will be webcast live and available on-demand via Weave’s investor relations website.
  • Weave serves approximately 40,000 customer locations.
  • The company was recognized as a 2026 Best Software Awards winner by G2.

Weave's participation in a high-profile investor conference signals an effort to bolster investor confidence and communicate its strategic direction. The company operates in a rapidly expanding vertical SaaS market, where demonstrating consistent growth and innovation is crucial for maintaining a premium valuation. The fireside chat will likely focus on Weave's AI capabilities and its ability to drive efficiency and revenue for healthcare practices.

Investor Sentiment
The content and tone of the fireside chat will reveal management’s perspective on recent performance and future growth prospects, which will be closely scrutinized by investors.
Growth Sustainability
The company’s ability to maintain its growth rate while scaling its platform and expanding into new healthcare specialties will be a key indicator of long-term success.
Competitive Landscape
The conference provides an opportunity to assess how Weave differentiates itself from competitors in the increasingly crowded patient engagement software market, and whether its AI-powered approach provides a sustainable advantage.

Weave Rises to #2 on G2's Healthcare Software Rankings Amid AI-Driven Discovery

  • Weave has been ranked #2 on G2’s 2026 Best Healthcare Software Products list.
  • G2 reaches over 100 million buyers annually and bases its awards on verified user reviews.
  • The award highlights Weave’s AI-powered products and experiences for healthcare practices.
  • Weave CEO Brett White attributes the recognition to reliance on the platform by tens of thousands of healthcare professionals.
  • G2’s co-founder and CEO, Godard Abel, emphasizes the increasing importance of credible reviews in AI-driven software discovery.

G2’s Best Software Awards are gaining prominence as buyers increasingly leverage AI to identify software solutions, shifting the emphasis from marketing claims to verifiable user feedback. Weave’s ranking underscores the growing importance of customer experience platforms in the healthcare sector, where efficiency and patient satisfaction are key drivers. This recognition validates Weave’s strategy of focusing on AI-powered solutions for small and medium-sized healthcare businesses, a market segment often underserved by larger enterprise software providers.

AI Reliance
The increasing reliance on AI-driven software discovery by buyers will likely intensify pressure on software vendors to maintain high review scores and demonstrable customer impact.
Review Integrity
G2’s methodology, which relies heavily on verified user reviews, will be scrutinized as the platform’s influence grows, potentially leading to changes in how awards are calculated.
Competitive Landscape
Weave’s position as #2 suggests a competitive landscape; the ability of competitors like Salesforce, HubSpot, Zoom, and Adobe to integrate similar AI-powered features will impact Weave’s future ranking.

Weave's Profitability Emerges as Growth Moderates

  • Weave reported Q4 2025 revenue of $63.4 million, a 17% year-over-year increase.
  • The company achieved record gross margins and operating income in Q4, alongside a GAAP loss from operations of $2.2 million.
  • Full-year 2025 revenue reached $239.0 million, also up 17% year-over-year, with non-GAAP income from operations hitting $4.1 million.
  • Weave added 4,628 net new customer locations in 2025, bringing the total to 39,625 locations.

Weave's results highlight the ongoing shift towards digital patient engagement solutions within the fragmented healthcare sector. The company's focus on AI-powered automation and strategic partnerships, like the one with CareCredit, positions it to capitalize on this trend, but achieving sustained profitability amidst rising competition and economic uncertainty will be crucial. The company's move to define itself as an 'always-on teammate' suggests a strategic pivot towards deeper integration and dependency, a potentially powerful but also risky proposition.

Growth Sustainability
While 17% revenue growth remains solid, the deceleration from prior periods warrants scrutiny, particularly as Weave matures and faces increased competition in the healthcare SaaS space.
Margin Expansion
The continued improvement in gross margins is encouraging, but the company's ability to sustain this trend will depend on managing operating expenses and scaling its AI-powered workflows effectively.
Customer Retention
The 93% Dollar-Based Net Retention Rate indicates strong customer loyalty, but any significant decline in this metric could signal increased churn and pricing pressure within the healthcare market.

Weave Integrates CareCredit Financing to Tackle Patient Payment Friction

  • Weave, a customer experience and payments platform for healthcare businesses, has partnered with Synchrony’s CareCredit to integrate patient financing directly into its platform.
  • The integration aims to streamline practice operations and improve patient access to financing for procedures where insurance coverage is insufficient.
  • According to Weave, 43% of customers using its payment product expressed willingness to exclusively use Weave’s payment services with CareCredit integration.
  • The integration allows practices to initiate CareCredit payments in-office or via text-to-pay links, and patients can apply for credit directly within Weave.
  • Scott Chandler (VP of Strategic Partnerships, Weave) and Greg Pierce (SVP Network Solutions, Synchrony) jointly highlighted the benefits of the partnership.

The partnership reflects a growing trend of embedding financial services directly into patient-facing healthcare platforms to address the persistent issue of patient financial burden and improve access to care. Synchrony, with CareCredit’s substantial $40 billion in outstanding credit balances, is strategically expanding its reach within the healthcare ecosystem. This integration positions Weave to capture a larger share of the healthcare payments market, which is increasingly moving towards digital and integrated solutions.

Adoption Rate
The actual uptake of the integrated CareCredit financing option by Weave’s existing customer base will be a key indicator of the partnership’s success and the willingness of healthcare practices to embrace this approach to patient financing.
Competitive Response
Other healthcare software providers will likely evaluate this integration and may explore similar partnerships to remain competitive in the market, potentially leading to a wave of integrated financing solutions.
Regulatory Scrutiny
Increased integration of financing options within healthcare platforms could draw regulatory attention regarding transparency, patient access, and potential predatory lending practices, requiring Weave and Synchrony to proactively address compliance concerns.

Weave Automates Dental Insurance Verification with RPA, Targeting $40B Market

  • Weave (NYSE: WEAV) launched Weave Insurance Eligibility (WIE), an RPA-powered solution for dental practices.
  • The new product integrates Robotic Process Automation (RPA) to retrieve real-time insurance data, addressing gaps in traditional EDI clearinghouses.
  • Vero Dental, a Weave customer, reports a transformative impact on administrative efficiency and reimbursement accuracy.
  • Weave claims WIE achieves an average insurance verification rate of 90%, significantly impacting practice profitability.
  • The dental software market is estimated at $40 billion, with a growing demand for automation and efficiency solutions.

Weave's move into RPA-powered insurance eligibility reflects a broader trend of automation within the healthcare sector, driven by rising administrative costs and a focus on patient experience. The dental software market, estimated at $40 billion, is ripe for disruption as practices seek to streamline operations and improve financial performance. This product positions Weave to capture a larger share of this market, but faces competition from established players and the need for continuous innovation.

Adoption Rate
The success of WIE hinges on rapid adoption across Weave’s existing customer base and attracting new dental practices seeking automation solutions; slower-than-expected adoption could limit revenue impact.
Competitive Response
Existing EDI clearinghouses and other dental software providers will likely respond with competing offerings, potentially eroding Weave’s market share and pricing power.
Integration Depth
The long-term value of WIE will depend on its ability to integrate seamlessly with various practice management systems and expand functionality beyond basic eligibility verification.
CID: 679